ALSAX | NRGSX | ALSAX / NRGSX | |
Total Expense Ratio | 1.34 | 0.74 | 181% |
Annual Report Gross Expense Ratio | 1.34 | 0.74 | 181% |
Fund Existence | 29 years | 13 years | - |
Gain YTD | 5.725 | -3.458 | -166% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 201M | 8.8B | 2% |
Annual Yield % from dividends | 0.00 | 0.06 | - |
Returns for 1 year | 6.95 | -7.18 | -97% |
Returns for 3 years | 32.42 | 9.33 | 348% |
Returns for 5 years | -18.80 | -1.44 | 1,302% |
Returns for 10 years | 38.72 | 10.14 | 382% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
AFMBX | 39.09 | 0.17 | +0.44% |
American Funds American Balanced F3 | |||
CECYX | 30.38 | N/A | N/A |
Columbia Large Cap Enhanced Core Inst3 | |||
GMCUX | 16.99 | N/A | N/A |
Goldman Sachs Small/Mid Cap Equity R6 | |||
PRIAX | 35.03 | N/A | N/A |
Principal Glb Emerging Markets A | |||
CVMAX | 22.22 | N/A | N/A |
Calvert Emerging Markets Equity A |